Estimating HPV DNA Deposition Between Sexual Partners Using HPV Concordance, Y Chromosome DNA Detection, and Self-reported Sexual Behaviors

J Infect Dis. 2017 Dec 5;216(10):1210-1218. doi: 10.1093/infdis/jix477.

Abstract

Background: Detection of human papillomavirus (HPV) DNA in genital samples may not always represent true infections but may be depositions from infected sexual partners. We examined whether sexual risk factors and a biomarker (Y chromosome DNA) were associated with genital HPV partner concordance and estimated the fraction of HPV detections potentially attributable to partner deposition.

Methods: The HITCH study enrolled young women attending a university or college in Montréal, Canada, and their male partners, from 2005 to 2010. We tested baseline genital samples for Y chromosome DNA and HPV DNA using polymerase chain reaction.

Results: Type-specific HPV concordance was 42.4% in partnerships where at least one partner was HPV DNA positive. Y chromosome DNA predicted type-specific HPV concordance in univariate analyses, but in multivariable models the independent predictors of concordance were days since last vaginal sex (26.5% higher concordance 0-1 vs 8-14 days after last vaginal sex) and condom use (22.6% higher concordance in never vs always users). We estimated that 14.1% (95% confidence interval [CI], 6.3-21.9%) of HPV DNA detections in genital samples were attributable to vaginal sex in the past week.

Conclusions: A substantial proportion of HPV DNA detections may be depositions due to recent unprotected vaginal sex.

Keywords: concordance; deposition; human papillomavirus; sexual behavior; transmission.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Alphapapillomavirus / classification
  • Alphapapillomavirus / genetics*
  • Biomarkers
  • Canada / epidemiology
  • Chromosomes, Human, Y
  • DNA, Viral
  • Female
  • Humans
  • Male
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / transmission
  • Papillomavirus Infections / virology*
  • Population Surveillance
  • Prevalence
  • Risk Factors
  • Sexual Behavior*
  • Sexual Partners*
  • Vagina / virology
  • Young Adult

Substances

  • Biomarkers
  • DNA, Viral

Grants and funding